ARVN
(NASDAQ)Arvinas, Inc.
$8.76-- (--)
Loading... - Market loading
Arvinas (ARVN) Stock Price & Financial Analysis
Arvinas Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$8.75 - $9.10
52-Week High$14.51
52-Week Low$6.97
Open$9.09
Volume735.97K
Average Volume (3M)802.92K
Market Cap560.64M
Shares Outstanding64.00M
Price to Sales (P/S)6.27
Price to Book (P/B)1.45
EV/EBITDA-2.05
Revenue (TTM)89.40M
Net Income (TTM)-221.30M
Free Cash Flow (TTM)-256.90M
EPS (TTM)$-3.22
Profit Margin-247.54%
Operating Margin-279.31%
Return on Equity (ROE)-57.21%
Debt to Equity0.02
50-Day MA$8.70
200-Day MA$10.51
52-Week Change9.50%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$8.75 - $9.10
52-Week High$14.51
52-Week Low$6.97
Open$9.09
Volume735.97K
Average Volume (3M)802.92K
Market Cap560.64M
Shares Outstanding64.00M
Price to Sales (P/S)6.27
Price to Book (P/B)1.45
EV/EBITDA-2.05
Revenue (TTM)89.40M
Net Income (TTM)-221.30M
Free Cash Flow (TTM)-256.90M
EPS (TTM)$-3.22
Profit Margin-247.54%
Operating Margin-279.31%
Return on Equity (ROE)-57.21%
Debt to Equity0.02
50-Day MA$8.70
200-Day MA$10.51
52-Week Change9.50%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About Arvinas
What is the current stock price for ARVN?
As of the latest trading session, ARVN stock trades at $8.76. The 52-week range is $6.97–$14.51, with a day range of $8.75–$9.10.
What is the P/E ratio for ARVN?
The P/E ratio (Price-to-Earnings) for ARVN is shown in the Key Statistics section. This valuation metric helps compare Arvinas, Inc. to industry peers.
Does ARVN pay dividends?
Arvinas does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for ARVN?
Based on 4 analysts, the consensus for ARVN is Buy.
What is the market cap of ARVN?
Arvinas's market capitalization is $560.6M, classifying it as a small-cap company. Arvinas operates in the Healthcare sector within the Biotechnology industry.